Regulatory Strategy

Global applications for MAA to deliver market access in the most efficient sequence considering EU, US, Asia, Japan, China and Latin America. 

This includes early access programmes, clinical trail strategy, importation and distribution solutions. 

Scientific Advice and Protocol Assistance can be sought at any time during drug development. It is We provide comprehensive support to our clients guiding them through the process to obtain meaningful advice and guidance as part of their drug development programme.

We have extensive experience in planning and organising Orphan and PIP’s for clients.

LE4D LTD is a SME status holder and qualifying clients can be associated to our SME status. We are fully equipped to guide and explain the process to ensure we can achieve a positive outcome. Areas of expertise include ATMP’s, orphan, medical devices and combination products.